FIELD: medicine.
SUBSTANCE: method involves the nasoenteric administration of 99mTc-pertechnetate into a small intestine at 1.0-14 MBq/kg diluted with normal saline to an amount of 20 ml. That is immediately followed by a dynamic scintigraphy by means of two-detector rotation gamma-chamber for 60 minutes with a gamma-chamber detection mounted above a projection of the intestine and liver. Following the examination results enables calculated an absorption coefficient of a radiopharmaceutical agent (K); thereafter the scintigraphy is continued in the mode of "The Whole Body", which provides a basis to determine a percentage of the radiopharmaceutical agent (A) absorbed from an intestinal lumen. If the absorption coefficient is less than 3 and the absorption is less than 50% from the administered radiopharmaceutical agent, the small intestinal malabsorption is stated. K is described by the scintigram forming the sharpest image of the liver and having an area of interest 100 pxls to be marked within a liver, which is followed by constructing an activity/time curve. K is calculated as a slope of the curve to a horizontal axis with using the first 4 minutes of the linear rise of the curve by formula: K=(y2-y1)/(t2-t1)×60, wherein K is the absorption coefficient, t1 and t2 are time distances, seconds; y1 is a pulse count within the time distance t1, y2 is a pulse count within the time distance t2. To calculate A, an area including the whole patient's body and an area covering the visualised enteric loops are marked on the scintigram. The calculation follows the formula: A=(n(b)-n(e))/n(e)×100%, wherein n(b) is the total pulse count recorded within the whole body; n(e) is the total pulse count recorded within the small intestine.
EFFECT: method provides the high information value of the examination ensured by the complex analysis of the enteric function parameters in the early postoperative period.
3 cl, 3 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DIAGNOSIS OF BILE OUTFLOW DISORDERS | 2021 |
|
RU2778007C1 |
METHOD FOR INFLAMMATION FOCI IDENTIFICATION BY THE METHOD OF POLY-ORGANIC SCINTIGRAPHY | 2017 |
|
RU2648877C1 |
RADIONUCLIDE METHOD FOR DETERMINING LIVER DYSFUNCTION AFTER ORTHOTOPIC TRANSPLANTATION | 2019 |
|
RU2718294C1 |
METHOD FOR EVALUATING INTESTINAL BARRIER PERMEABILITY | 1999 |
|
RU2156110C1 |
DIAGNOSTIC TECHNIQUE FOR SURGICAL THYROID DISEASES USING DYNAMIC DOUBLE-INDICATOR SCINTIGRAPHY | 2019 |
|
RU2726601C1 |
AGENT AND METHOD FOR DIAGNOSIS OF SUPPURATIVE-INFLAMMATORY PROCESSES | 2005 |
|
RU2290952C1 |
METHOD FOR DETERMINING ABSORBING ABILITY DISTURBANCES IN SMALL INTESTINE | 0 |
|
SU1757641A1 |
METHOD FOR RADIONUCLIDE MARKING INTESTINE BACILLUS MICROORGANISM FOR SCINTIGRAPHIC INVESTIGATION | 2005 |
|
RU2290643C1 |
METHOD OF QUANTITATIVE ASSESSMENT OF DEGREE OF CELLULAR PREPARATION RETENTION WITHIN TARGET ORGAN WHEN INTRAORGAN ADMINISTRATION USING RADIONUCLIDE METHOD | 2022 |
|
RU2809526C2 |
METHOD FOR DIAGNOSTICS OF INFLAMMATORY PROCESS IN LUNGS AND IN INTRATHORACIC LYMPH NODES IN PATIENTS WITH SARCOIDOSIS | 2016 |
|
RU2638447C1 |
Authors
Dates
2015-06-10—Published
2014-07-11—Filed